Cargando…
Costing RTS,S introduction in Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda: A generalizable approach drawing on publicly available data
Recent results from the phase 3 trial of RTS,S/AS01 malaria vaccine show that the vaccine induced partial protection against clinical malaria in infants and children; given the high burden of the disease it is currently considered for use in malaria endemic countries. To inform adoption decisions th...
Autores principales: | Galactionova, Katya, Bertram, Melanie, Lauer, Jeremy, Tediosi, Fabrizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357730/ https://www.ncbi.nlm.nih.gov/pubmed/26518406 http://dx.doi.org/10.1016/j.vaccine.2015.10.079 |
Ejemplares similares
-
Adequacy of Some Locally Produced Complementary Foods Marketed in Benin, Burkina Faso, Ghana, and Senegal
por: Dimaria, Sara Antonio, et al.
Publicado: (2018) -
Nutrient Profiles of Commercially Produced Complementary Foods Available in Burkina Faso, Cameroon, Ghana, Nigeria and Senegal
por: Khosravi, Asha, et al.
Publicado: (2023) -
HIV testing and care in Burkina Faso, Kenya, Malawi and Uganda: ethics on the ground
por: Obermeyer, Carla Makhlouf, et al.
Publicado: (2013) -
Health Providers’ Perceptions of Clinical Trials: Lessons from Ghana, Kenya and Burkina Faso
por: Angwenyi, Vibian, et al.
Publicado: (2015) -
Insights from modelling malaria vaccines for policy decisions: the focus on RTS,S
por: Galactionova, Katya, et al.
Publicado: (2021)